Personalis, Inc.
NASDAQ:PSNL
Overview | Financials
Company Name | Personalis, Inc. |
Symbol | PSNL |
Currency | USD |
Price | 4.32 |
Market Cap | 229,282,704 |
Dividend Yield | 0% |
52-week-range | 0.891 - 7.2 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Christopher M. Hall |
Website | https://www.personalis.com |
An error occurred while fetching data.
About Personalis, Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD